Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 23, 2025
METTL5 Enables Immune Evasion of Liver Cancer via Chemokine mRNA Translation RegulationShuang Li, Xiao Zhao, Tongtong Song, et al.Gut|January 3, 2023
Distinct single-cell immune ecosystems distinguish true and de novo HBV-related hepatocellular carcinoma recurrencesShuling Chen, Cheng Huang, Guanrui Liao, et al.Gut|May 12, 2019
Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinomaMan Liu, Jingying Zhou, Xiaoyu Liu, et al.Cancer Immunology Research|April 27, 2022
Combination Neoantigen-Based Dendritic Cell Vaccination and Adoptive T-Cell Transfer Induces Antitumor Responses Against Recurrence of Hepatocellular CarcinomaSui Peng, Shuling Chen, Wei Hu, et al.Cellular & Molecular Immunology|September 4, 2020
Cell cycle-related kinase reprograms the liver immune microenvironment to promote cancer metastasisXuezhen Zeng, Jingying Zhou, Zhewen Xiong, et al.Nature Communications|December 8, 2018
An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinomaHanyong Sun, Weiqin Yang, Yuan Tian, et al.Gut|April 5, 2023
Targeting PPAR-gamma counteracts tumour adaptation to immune-checkpoint blockade in hepatocellular carcinomaZhewen Xiong, Stephen Lam Chan, Jingying Zhou, et al.Cellular & Molecular Immunology|May 20, 2022
Aberrant cholesterol metabolic signaling impairs antitumor immunosurveillance through natural killer T cell dysfunction in obese liverWenshu Tang, Jingying Zhou, Weiqin Yang, et al.Pageof 3